Indo US Bio-Tech [INDOUS] vs UPL [UPLPP] Detailed Stock Comparison

Indo US Bio-Tech

NSE
Loading...

UPL

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Indo US Bio-Tech wins in 8 metrics, UPL wins in 11 metrics, with 0 ties. UPL appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricIndo US Bio-TechUPLBetter
P/E Ratio (TTM)16.153.00UPL
Price-to-Book Ratio3.631.63UPL
Debt-to-Equity Ratio18.90105.06Indo US Bio-Tech
PEG RatioN/A-0.05N/A
EV/EBITDA14.4513.32UPL
Profit Margin (TTM)16.20%0.09%Indo US Bio-Tech
Operating Margin (TTM)17.13%13.51%Indo US Bio-Tech
EBITDA Margin (TTM)17.13%13.51%Indo US Bio-Tech
Return on Equity20.72%2.01%Indo US Bio-Tech
Return on Assets (TTM)16.63%0.86%Indo US Bio-Tech
Free Cash Flow (TTM)$5.57M$84.56BUPL
Dividend Yield0.16%0.69%UPL
1-Year Return-51.11%104.96%UPL
Price-to-Sales Ratio (TTM)2.631.38UPL
Enterprise Value$3.03B$724.61BUPL
EV/Revenue Ratio2.751.61UPL
Gross Profit Margin (TTM)28.10%54.76%UPL
Revenue per Share (TTM)$55$570UPL
Earnings per Share (Diluted)$8.91$-0.74Indo US Bio-Tech
Beta (Stock Volatility)-0.650.83Indo US Bio-Tech
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Indo US Bio-Tech vs UPL Stock Performance Analysis

Loading Price Chart...

Indo US Bio-Tech
UPL
Indo US Bio-Tech Stock Overview | UPL Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Indo US Bio-Tech-0.19%-3.50%-8.95%-5.58%-8.14%-52.18%
UPL0.00%0.00%0.00%22.03%96.43%129.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Indo US Bio-Tech-51.11%-51.11%-51.11%-51.11%-51.11%-51.11%
UPL104.96%104.96%104.96%104.96%104.96%104.96%

News Based Sentiment: Indo US Bio-Tech vs UPL

Indo US Bio-Tech

News based Sentiment: MIXED

September was a month of contrasts for Indo US Bio-Tech, with positive financial results battling against recent stock declines and overall underperformance. The upcoming AGM on September 30th is a critical event that will likely shape the company's direction and investor sentiment.

View Indo US Bio-Tech News Sentiment Analysis

UPL

News based Sentiment: POSITIVE

September was a pivotal month for UPL Ltd. with a major strategic restructuring announcement and a shareholder vote scheduled. Despite some stock volatility, the company demonstrated strong six-month returns and maintained positive analyst sentiment, suggesting a generally favorable outlook for investors.

View UPL News Sentiment Analysis

Performance & Financial Health Analysis: Indo US Bio-Tech vs UPL

MetricINDOUSUPLPP
Market Information
Market Cap i₹2.90B₹620.31B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i15,8311,096
90 Day Avg. Volume i26,452441
Last Close₹142.78₹516.50
52 Week Range₹138.13 - ₹388.40₹216.20 - ₹563.85
% from 52W High-63.24%-8.40%
All-Time High₹388.40 (Dec 09, 2024)₹563.85 (Jul 30, 2025)
% from All-Time High-63.24%-8.40%
Growth Metrics
Quarterly Revenue Growth0.25%0.10%
Quarterly Earnings Growth0.48%0.02%
Financial Health
Profit Margin (TTM) i0.16%0.00%
Operating Margin (TTM) i0.17%0.14%
Return on Equity (TTM) i0.21%0.02%
Debt to Equity (MRQ) i18.90105.06
Cash & Liquidity
Book Value per Share (MRQ)₹39.64₹318.92
Cash per Share (MRQ)₹0.12₹51.99
Operating Cash Flow (TTM) i₹34.25M₹70.93B
Levered Free Cash Flow (TTM) i₹162.67M₹7.59B
Dividends
Last 12-Month Dividend Yield i0.16%0.69%
Last 12-Month Dividend i₹0.25₹3.00

Valuation & Enterprise Metrics Analysis: Indo US Bio-Tech vs UPL

MetricINDOUSUPLPP
Price Ratios
P/E Ratio (TTM) i16.153.00
Forward P/E iN/AN/A
PEG Ratio iN/A-0.05
Price to Sales (TTM) i2.631.38
Price to Book (MRQ) i3.631.63
Market Capitalization
Market Capitalization i₹2.90B₹620.31B
Enterprise Value i₹3.03B₹724.61B
Enterprise Value Metrics
Enterprise to Revenue i2.751.61
Enterprise to EBITDA i14.4513.32
Risk & Other Metrics
Beta i-0.650.83
Book Value per Share (MRQ) i₹39.64₹318.92

Financial Statements Comparison: Indo US Bio-Tech vs UPL

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)INDOUSUPLPP
Revenue/Sales i₹333.85M₹92.16B
Cost of Goods Sold i₹244.12M₹41.69B
Gross Profit i₹89.72M₹50.47B
Research & Development iN/AN/A
Operating Income (EBIT) i₹40.19M₹7.64B
EBITDA i₹47.02M₹14.78B
Pre-Tax Income i₹38.79M₹-1.90B
Income Tax i₹1.94M₹-140.00M
Net Income (Profit) i₹36.85M₹-1.76B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)INDOUSUPLPP
Cash & Equivalents i₹2.48M₹94.78B
Total Current Assets i₹867.27M₹396.61B
Total Current Liabilities i₹163.39M₹285.69B
Long-Term Debt i₹29.34M₹192.56B
Total Shareholders Equity i₹785.19M₹378.26B
Retained Earnings iN/A₹208.68B
Property, Plant & Equipment i₹102.34M₹94.31B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)INDOUSUPLPP
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricINDOUSUPLPP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i15,8311,096
Average Daily Volume (90 Day) i26,452441
Shares Outstanding i20.05M844.43M
Float Shares i4.12M563.84M
% Held by Insiders i0.77%0.00%
% Held by Institutions i0.00%0.17%

Dividend Analysis & Yield Comparison: Indo US Bio-Tech vs UPL

MetricINDOUSUPLPP
Last 12-Month Dividend i₹0.25₹3.00
Last 12-Month Dividend Yield i0.16%0.69%
3-Year Avg Annual Dividend i₹0.08₹1.00
3-Year Avg Dividend Yield i0.09%0.69%
3-Year Total Dividends i₹0.25₹3.00
Ex-Dividend DateDec 03, 2024Jul 11, 2025